# Axsome Therapeutics Reports Q3 Revenue Up 51.9% to $259.7 Million

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/46451
Published: 2026-11-02T13:14:59.000Z
Updated: 2026-11-02T13:14:59.000Z
Section: Business

> Its GAAP loss was 25 cents per share, 38 cents better than estimates. Shares gained 2.5% in premarket trading.

Axsome Therapeutics, Inc. reported third-quarter revenue of $259.7 million, a 51.9% increase from a year earlier and $10.51 million above estimates. The company recorded a GAAP loss of 25 cents per share, 38 cents better than estimates.

Axsome shares rose 2.5% in premarket trading.